Arcos Dorados Holdings Inc. is rated a Buy due to its strong Q3 comparable sales growth of 15.5%, driven by increased customer traffic, higher spending per visit, and market share gains. Despite challenges like currency volatility, labor inflation, and regulatory risks in Latin America, the company maintains a healthy balance sheet that supports a 4% forward dividend yield and share repurchases. However, its adjusted EBITDA margin slightly declined by 0.2 percentage points, and cost pressures may limit its ability to pass expenses to customers without affecting traffic. The company targets mid-to-high single-digit revenue growth and faster EBITDA growth going forward.
Arcos Dorados Q3 results provide context for consumer cyclical stocks, with data as of Nov 14, 2026 00:51 WIB. Among 134 priced US consumer cyclical stocks on Pluang, 85 rose and 48 fell today. Notable movers include ARKO at USD 3.98 with a 3.05% decline, YUMC at USD 50.65 gaining 2.93%, and ANF at USD 146.13 down 2.90%.
The Organic Grower Summit (OGS) 2026, held Dec. 2–3 in Monterey, California, introduces an exclusive offsite AGTech Reception & Field Demos at Reservoir Farms. Sponsored by John Deere, Western Growers Association, and Reservoir, this event offers gro...
At the 31st Annual Society for Neuro-Oncology meeting, biotech firms NeOnc, Nuvation Bio, Jazz Pharmaceuticals, and Cerenome presented new clinical data on brain cancer treatments. Highlights include NeOnc's NEO100 and NEO212 therapies advancing towa...
Subsea 7 has secured a sizeable contract from Kosmos Energy for the Tiberius Project in the US Gulf of Mexico, involving fabrication and installation of subsea infrastructure at about 2,200 meters depth. The work includes a 14-kilometer steel riser, ...
GlobeNewswire released its End of Day Message for November 13, 2026, confirming its role as an FCA-approved primary information provider. The update mainly reiterates its operational status and disclaimers, without reporting any new financial events ...
Space42, a UAE-based space technology company, announced strong financial results for the first nine months of 2026, with revenue up 11% to $404 million and normalized EBITDA rising 30% to $194 million. Growth was driven by its two main divisions: Sp...
